Cat. No. | Product name | CAS No. | Purity | Chemical Structure |
---|---|---|---|---|
T67868 | Oleana-2,12-dien-28-oic acid | 272108-04-0 | 99.69% |
|
Oleana-2,12-dien-28-oic acid is an HBsAg and HBeAg inhibitor that obviously inhibit HBV deoxyribonucleic acid (HBV-DNA) replication in HepG2.2.15 cells. Oleana-2... | ||||
T63971 | Canocapavir | 2137847-19-7 | 98.40% |
|
Canocapavir (ZM-H1505R) is a novel orally available HBV coat protein modulator with antiviral activity that induces conformational changes in the linker region o... | ||||
TN1840 | Kurarinol | 855746-98-4 | 98% |
|
Kurarinol is a potent inhibitor of sortase A, with an IC50 value of 107.7 ± 6.6 μM. Kurarinol has extremely strong tyrosinase inhibitory activity, exerts varying... | ||||
T78756 | Yhhu6669 | 2569526-80-1 | 98% |
|
Yhhu6669 is an anti-HBV agent that suppresses viral DNA and replication by promoting DNA-free capsid assembly, effectively reducing HBV DNA and HBcAg levels in A... | ||||
T78783 | HBV-IN-35 | 98% |
|
|
Compound HBV-IN-35 (Compound 88) serves as an HBV inhibitor and exhibits anti-HBV activity in both mouse and human hepatocytes with EC50 values of 100 nM and 400... | ||||
T78812 | HBV-IN-36 | 98% |
|
|
HBV-IN-36 (also known as compound 42) is a hepatitis B virus (HBV) inhibitor with an IC50 of 2 μM, exhibiting anti-HBV activity characterized by an EC50 of 0.58 ... | ||||
T79469 | HBV-IN-34 | 2716906-45-3 | 98% |
|
HBV-IN-34 (compound 17i) is a potent inhibitor of HBsAg production, demonstrating remarkable in vitro anti-HBV efficacy with EC50 values of 0.018 μM for HBV DNA ... | ||||
T79650 | HBV-IN-40 | 98% |
|
|
HBV-IN-40 (Compound 11826096), with an IC50 of 0.7 µM, serves as a potent HBV inhibitor and exhibits antiviral activity [1]. | ||||
T79767 | HBV-IN-41 | 1967002-25-0 | 98% |
|
HBV-IN-41 (compound 45) is a potent, orally active inhibitor of Hepatitis B Virus (HBV), exhibiting an EC50 value of 0.027μM [1]. | ||||
T79879 | HBV-IN-38 | 1834483-86-1 | 98% |
|
HBV-IN-38 (Example 193), an HBV DNA inhibitor with an EC50 value of ≤100 nM, serves as a research tool for investigating viral infections [1]. | ||||
T79975 | Dihydrodehydrodiconiferyl alcohol 9-O-α-L-rhamnopyranoside | 1252572-36-3 | 98% |
|
Dihydrodehydrodiconiferyl alcohol 9-O-α-L-rhamnopyranoside (Compound 1), a lignan with anti-HBV activity, exhibits selectivity by targeting the HBV surface antig... | ||||
T79976 | Dihydrodehydrodiconiferyl alcohol 9-O-β-D-xylopyranoside | 1015175-06-0 | 98% |
|
Dihydrodehydrodiconiferyl alcohol 9-O-β-D-xylopyranoside serves as an anti-hepatitis B virus (anti-HBV) agent, effectively inhibiting the secretion of HBV surfac... | ||||
T80649 | Oxynitidine | 548-31-2 | 98% |
|
Oxynitidine, an HBV inhibitor (ID50 = 30.8 µg/mL), effectively suppresses HBV DNA replication and may be utilized in viral infection research [1]. | ||||
T80970 | Tobevibart | 2645440-65-7 | 98% |
Tobevibart
|
Tobevibart, an IgG1-lambda humanized monoclonal antibody targeting the hepatitis B virus (HBV) surface envelope protein, exhibits antiviral activity [1]. | ||||
T7365 | Inarigivir | 475650-36-3 | 98% |
|
Inarigivir (ORI-9020) is a dinucleotide that can significantly reduce liver HBV DNA. | ||||
T10480L | Bay 41-4109 | 298708-81-3 | 98% |
|
BAY 41-4109 is a potent inhibitor of human hepatitis B virus (HBV)(IC50 : 53 nM). | ||||
T10480 | Bay 41-4109 (less active enantiomer) | 476617-51-3 | 98% |
|
Bay 41-4109 less active enantiomer shows less activity than Bay 41-4109. BAY 41-4109 is a potent HBV inhibitor (IC50: 53 nM). | ||||
T16870 | Selgantolimod | 2004677-13-6 | 98% |
|
Selgantolimod is an effective and selective toll-like receptor 8 agonists for the treatment of the hepatitis B virus and human immunodeficiency virus infection. | ||||
TN2220 | Sophoranol | 3411-37-8 | 98% |
|
(+)-Sophoranol exhibits antiviral activity against the Coxsackie virus B3. It also shows potent anti-HBV activity with an inhibitory potency against HBsAg secret... | ||||
T12724 | RIG-1 modulator 1 | 1428729-63-8 | 98% |
|
RIG-1 modulator 1 is useful for the treatment of viral infections including influenza virus, HBV, HCV and HIV. |